UPDATE 1-Drugmakers see a pricing blueprint in an $850000 gene therapy – Reuters
|
UPDATE 1-Drugmakers see a pricing blueprint in an $850000 gene therapy
Reuters “We're laying the groundwork for the future of our pipeline and the future of one-time curative gene therapy treatments,” Spark's chief executive officer, Jeffrey Marrazzo, said in an interview at the JPMorgan Healthcare Conference in San Francisco … |
